XML 27 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment and Geographic Information
 6 Months Ended
Nov. 30, 2015
Segment Reporting [Abstract]  
Segment and Geographic Information
SEGMENT AND GEOGRAPHIC INFORMATION
We consider our business to be a single operating segment entity engaged in the development, manufacture and sale on a global basis of medical devices for vascular access, peripheral vascular disease, oncology and surgery. Our chief operating decision maker (CEO) evaluates the various global product portfolios on a net sales basis. Executives reporting to the CEO include those responsible for commercial operations, manufacturing operations, regulatory and quality and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources.
The table below summarizes net sales by product category (in thousands of dollars): 
 
Three Months Ended
 
Six Months Ended
 
Nov 30, 2015
 
Nov 30, 2014
 
Nov 30, 2015
 
Nov 30, 2014
Net sales
 
 
 
 
 
 
 
Peripheral Vascular
$
51,051

 
$
49,440

 
$
98,158

 
$
96,801

Vascular Access
25,023

 
27,968

 
49,667

 
54,393

Oncology/Surgery
12,422

 
13,634

 
23,706

 
25,996

Supply Agreement
738

 
1,107

 
1,406

 
2,290

Total
$
89,234

 
$
92,149

 
$
172,937

 
$
179,480


The table below presents net sales by geographic area based on external customer location (in thousands of dollars):
 
 
Three Months Ended
 
Six Months Ended
 
Nov 30, 2015
 
Nov 30, 2014
 
Nov 30, 2015
 
Nov 30, 2014
Net sales
 
 
 
 
 
 
 
United States
$
70,651

 
$
72,058

 
$
139,021

 
$
140,438

International
17,845

 
18,984

 
32,510

 
36,752

Supply Agreement
738

 
1,107

 
1,406

 
2,290

Total
$
89,234

 
$
92,149

 
$
172,937

 
$
179,480